These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1006320)

  • 1. [Medium and long term study of clofibride in the treatment of atherogenic hyperlipidemia. Statistical approach to the results].
    Fromantin M; Garraud R; Auriche M
    Sem Hop Ther; 1976 Nov; 52(9):455-64. PubMed ID: 1006320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimentation with Atherulip 500 (apropos of 30 cases)].
    Jaillard J
    Lille Med; 1976 Dec; 21 Suppl 4():915-8. PubMed ID: 1018618
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of arteriosclerosis].
    Schwandt P
    Internist (Berl); 1973 Jul; 14(7):325-9. PubMed ID: 4582163
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective lipid therapy].
    MMW Munch Med Wochenschr; 1978 Dec; 120(50):22. PubMed ID: 102985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 10. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 13. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
    Kritchevsky D
    Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clofibrate treatment of hyperlipidemia in long-term dialysis patients].
    Wessels G; Müller H; Busch G; Loew H
    Med Welt; 1976 Nov; 27(47):2278-9. PubMed ID: 826753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB; Hartmann G
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of hyperlipidemic states].
    Lipovetskiĭ BM; Triufanov VF; Konstantinov VO
    Klin Med (Mosk); 1980 Apr; 58(4):56-61. PubMed ID: 7382369
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
    Scherhag R
    Fortschr Med; 1983 Sep; 101(36):1635-7. PubMed ID: 6629296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
    Cagánová A; Cagán S
    Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.